NCT06497907

Brief Summary

The study was conducted on 200 patients with growth faltering on 2 phases. In the first phase the patient received nutritional rehabilitation with polymeric formula for 12 weeks then they were reassessed by anthropometric measurements and those whose weight remained below -2 SD for age and sex on the WHO scores were defined as non responders and entered the second phase. In the second phase Upper Gastrointestinal endoscopy was done and then patients received nutritional rehabilitation with peptide based formula and probiotics then were reassessed after 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

1.1 years

First QC Date

June 25, 2024

Last Update Submit

July 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of the prevalence of environmental enteropathy among children with faltering growth.

    Assess the number of patients whose weight still below -2SD and upper gastrointestinal endoscopy showed the criteria of environmental enteropathy.

    12 weeks of nutritional rehabilitation with polymeric formula.

Secondary Outcomes (1)

  • Determine the increase in weight of children with growth faltering and environmental enteropathy after nutritional rehabilitation with peptide-based formula.

    8 weeks of nutritional rehabilitation with peptide-based formula.

Study Arms (1)

Patients with growth faltering

EXPERIMENTAL

Patient with growth faltering whose weight still below -2 SD for age and sex on the WHO scores after 12 weeks of nutritional rehabilitation with polymeric formula, underwent upper gastrointestinal endoscopy and who were diagnosed as environmental enteropathy, received nutritional rehabilitation with peptide based formula for 8 weeks and were reassessed.

Dietary Supplement: polymeric formulaDietary Supplement: peptide based formula

Interventions

polymeric formulaDIETARY_SUPPLEMENT

Patients with growth faltering received nutritional rehabilitation with polymeric formula and were reassessed after 12 weeks by anthropometric measurements

Patients with growth faltering
peptide based formulaDIETARY_SUPPLEMENT

patients who were defined as non responders and underwent upper gastrointestinal endoscopy and diagnosed as environmental enteropathy, received nutritional rehabilitation with peptide based formula

Patients with growth faltering

Eligibility Criteria

Age6 Months - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients whose weight below -2 SD for age and sex on the WHO scores.

You may not qualify if:

  • Secondary cases of malnutrition or undernutrition.
  • Patients with symptoms of GIT problems as chronic vomiting, chronic or bloody diarrhea, chronic abdominal distension, hematemesis or bleeding per rectum.
  • Patients who can't commit to a follow up visit every two weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine-Ain Shams University

Cairo, Abbasia, 1181, Egypt

Location

MeSH Terms

Conditions

Failure to ThriveIntestinal Diseases

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patient with growth faltering whose weight still below -2 SD for age and sex on the WHO scores after 12 weeks of nutritional rehabilitation with polymeric formula, underwent upper gastrointestinal endoscopy and who were diagnosed as environmental enteropathy, received nutritional rehabilitation with peptide based formula and probiotics
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of pediatrics

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 12, 2024

Study Start

April 30, 2022

Primary Completion

June 12, 2023

Study Completion

June 25, 2024

Last Updated

July 12, 2024

Record last verified: 2024-07

Locations